Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion type Assertion NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_head.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion description "[We aimed to validate the impact of GSTT1 and GSTM1 deletions and of the GSTP1Ile105Val polymorphism on outcome and toxicity in 140 patients with advanced Hodgkin's lymphoma enrolled in the prospective multicenter HD2000-GISL trial, comparing ABVD, BEACOPP and CEC regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_provenance.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion evidence source_evidence_literature NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_provenance.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion SIO_000772 21916526 NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_provenance.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion wasDerivedFrom befree-2016 NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_provenance.
- NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_assertion wasGeneratedBy ECO_0000203 NP923717.RAXzvXY_sw6WBiqbpj7chn1jBBtpq3D2O_xhg--KmuSFk130_provenance.